We found BRAFV600E mutation and RTK fusions enriched in MSI-H CRC patients, but KRASG12C mutation and ERBB2 (HER2) amplification only occurred in MSS CRC patients (Supplementary Figure 2). This evidence concerns the gene ERBB2 and colorectal carcinoma.